Drug Profile
Research programme: antibiotic-resistant infection therapeutics - Agile Sciences
Alternative Names: 2-AI compounds; Agilyte; AGL-110; AGL-503Latest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator North Carolina State University
- Developer Agile Sciences
- Class Imidazoles; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections; Pseudomonal infections; Wound infections
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 04 Sep 2023 Discontinued - Preclinical for Pseudomonal infections in USA (unspecified route)
- 04 Sep 2023 Discontinued - Preclinical for Wound infections in USA (unspecified route)